Conferences - Results from #340

EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Arguments for a Surgical Approach +/- Radiotherapy +/- Systemic Treatment March 13, 2023

EAU 2023: Debate: Low-Volume Disease at Conventional Imaging, 5 Bone Metastases at PSMA PET/CT March 13, 2023

EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Arguments for a Radiotherapeutic Approach +/- Systemic Treatment March 13, 2023

EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Subtypes of Prostate Cancer and How They Change our Management March 13, 2023

EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: Systemic Therapy: What and for how long? March 13, 2023

EAU 2023: State-of-the-Art Lecture: Patient-Related Factors That Guide Treatment Decisions March 13, 2023

Delaying Treatment for Localised Prostate Cancer Does Not Increase Mortality Risk, Trial Shows March 12, 2023

Difference Between “Growers” and “Showers” Revealed March 12, 2023

EAU 2023: State-of-the-Art Lecture When and How to Stage? March 12, 2023

EAU 2023: Debate: High-Risk BRCA Mutated Case with N0 M0 at Conventional Imaging and Multiple cN1 at PSMA: What to Do? March 12, 2023

EAU 2023: LuTectomy: A Prospective Study of Dosimetry, Safety and Potential Benefit of Upfront 177Lu-PSMA-617 Radioligand Therapy Prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer March 12, 2023

EAU 2023: Patient with High-Risk Localized Disease, M0 on Conventional Imaging but One Bone Lesion on PSMA PET/CT: How to Treat a Frail and Elderly Patient in this Situation March 12, 2023

EAU 2023: State-of-the-Art Lecture: Germ Line Testing in Hormone-Sensitive Prostate Cancer: When and Why? March 12, 2023

EAU 2023: PSMA-PET in Local Evaluation of the Prostate for Active Surveillance? No March 12, 2023

EAU 2023: State-of-the-Art Lecture: In Which Patients with Low-Volume mHSPC Should We Use Metastases-Directed Therapy? March 12, 2023

EAU 2023: Artificial Intelligence to Improve Cytology Performance in Bladder Urothelial Carcinoma Diagnosis: Results of the French, Multicenter, Prospective VISIOCYT1 Trial March 12, 2023

UK Study Finds Vasectomies Are Even Safer than Reported March 12, 2023

EAU 2023: The Efficacy of Red Channel Enhanced Images for AI Segmentation of Bladder Tumors in Cystoscopic Images March 12, 2023

EAU 2023: PSMA-PET in Local Evaluation of the Prostate for Active Surveillance? Yes March 12, 2023

EAU 2023: How to Manage Active Surveillance in 2023 - Do We Need a Genetic Biopsy Test to Promote AS in GG2 Cancers? March 12, 2023

Page 18 of 522